Virtu Financial’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,911
| Closed | -$434K | – | 1451 |
|
|
2025
Q1 | $434K | Sell |
5,911
-4,216
| -42% | -$310K | 0.02% | 537 |
|
|
2024
Q4 | $663K | Sell |
10,127
-51,770
| -84% | -$3.39M | 0.04% | 419 |
|
|
2024
Q3 | $4.82M | Buy |
+61,897
| New | +$4.82M | 0.27% | 48 |
|
|
2024
Q1 | – | Sell |
-4,092
| Closed | -$276K | – | 1409 |
|
|
2023
Q4 | $276K | Buy |
+4,092
| New | +$276K | 0.02% | 636 |
|
|
2023
Q3 | – | Sell |
-3,577
| Closed | -$256K | – | 1298 |
|
|
2023
Q2 | $256K | Buy |
+3,577
| New | +$256K | 0.02% | 686 |
|
|
2022
Q4 | – | Sell |
-37,809
| Closed | -$2.07M | – | 1597 |
|
|
2022
Q3 | $2.07M | Buy |
+37,809
| New | +$2.07M | 0.19% | 87 |
|
|
2022
Q2 | – | Sell |
-7,529
| Closed | -$499K | – | 1576 |
|
|
2022
Q1 | $499K | Buy |
+7,529
| New | +$499K | 0.04% | 392 |
|
|
2020
Q4 | – | Sell |
-4,489
| Closed | -$246K | – | 1430 |
|
|
2020
Q3 | $246K | Sell |
4,489
-4,271
| -49% | -$234K | 0.04% | 515 |
|
|
2020
Q2 | $463K | Buy |
+8,760
| New | +$463K | 0.05% | 395 |
|
|
2019
Q4 | $777K | Buy |
+15,583
| New | +$777K | 0.08% | 291 |
|
|
2019
Q3 | – | Sell |
-4,896
| Closed | -$202K | – | 1417 |
|
|
2019
Q2 | $202K | Buy |
+4,896
| New | +$202K | 0.01% | 1001 |
|
|
2018
Q4 | – | Sell |
-6,021
| Closed | -$238K | – | 1539 |
|
|
2018
Q3 | $238K | Sell |
6,021
-25,061
| -81% | -$991K | 0.01% | 974 |
|
|
2018
Q2 | $1.09M | Buy |
+31,082
| New | +$1.09M | 0.07% | 347 |
|
|
2018
Q1 | – | Sell |
-7,084
| Closed | -$246K | – | 1942 |
|
|
2017
Q4 | $246K | Buy |
+7,084
| New | +$246K | 0.01% | 1448 |
|
|
2017
Q2 | – | Sell |
-7,780
| Closed | -$242K | – | 384 |
|
|
2017
Q1 | $242K | Buy |
+7,780
| New | +$242K | 0.03% | 335 |
|